Literature DB >> 23740716

FMR1 CGG expansions: prevalence and sex ratios.

Matthew J Maenner1, Mei W Baker, Karl W Broman, Jianan Tian, Janel K Barnes, Anne Atkins, Elizabeth McPherson, Jinkuk Hong, Murray H Brilliant, Marsha R Mailick.   

Abstract

We have estimated the prevalence of FMR1 premutation and gray zone CGG repeat expansions in a population-based sample of 19,996 male and female adults in Wisconsin and compared the observed sex ratios of the prevalence of FMR1 CGG premutation and gray zone expansions to theoretical sex ratios. The female premutation prevalence was 1 in 148 and comparable to past research, but the male premutation prevalence of 1 in 290 is somewhat higher than most previous estimates. The female:male premutation prevalence ratio is in line with the theoretically predicted sex ratio. The prevalence of CGG repeats in the gray zone (45-54 repeats) was 1 in 33 females and 1 in 62 males. The prevalence of the "expanded" gray zone (defined here as 41-54 CGG repeats) was 1 in 14 females and 1 in 22 males, leading to a female:male ratio of 1.62 (95% confidence interval 1.39-1.90). This female:male ratio was significantly lower than the expected ratio of 2.0. We examined results from three previously published FMR1 prevalence studies and found similar female:male ratios for CGG repeats in this "expanded" gray zone range (pooled female:male ratio across all four studies 1.66, 95% confidence interval 1.51-1.82). Further research is needed to understand the apparent excess prevalence of males with CGG repeats in this range.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740716      PMCID: PMC3885228          DOI: 10.1002/ajmg.b.32176

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  31 in total

1.  Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers.

Authors:  Deborah Hall; Flora Tassone; Olga Klepitskaya; Maureen Leehey
Journal:  Mov Disord       Date:  2011-12-11       Impact factor: 10.338

Review 2.  Screening for fragile X syndrome: a literature review and modelling study.

Authors:  F J Song; P Barton; V Sleightholme; G L Yao; A Fry-Smith
Journal:  Health Technol Assess       Date:  2003       Impact factor: 4.014

3.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

4.  Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.

Authors:  Gloria E Hoffman; Wei Wei Le; Ali Entezam; Noriyuki Otsuka; Zhi-Bin Tong; Lawrence Nelson; Jodi A Flaws; John H McDonald; Sanjeeda Jafar; Karen Usdin
Journal:  J Histochem Cytochem       Date:  2012-04-02       Impact factor: 2.479

5.  Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range.

Authors:  Amy K Sullivan; Dana C Crawford; Elizabeth H Scott; Mary L Leslie; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2002-05-03       Impact factor: 11.025

6.  Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.

Authors:  H Toledano-Alhadef; L Basel-Vanagaite; N Magal; B Davidov; S Ehrlich; V Drasinover; E Taub; G J Halpern; N Ginott; M Shohat
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

Review 7.  The fragile-X premutation: a maturing perspective.

Authors:  Paul J Hagerman; Randi J Hagerman
Journal:  Am J Hum Genet       Date:  2004-03-29       Impact factor: 11.025

Review 8.  The FMR1 gene and fragile X-associated tremor/ataxia syndrome.

Authors:  J R Brouwer; R Willemsen; B A Oostra
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

9.  Clinical significance of tri-nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines.

Authors:  Kathryn E Kronquist; Stephanie L Sherman; Elaine B Spector
Journal:  Genet Med       Date:  2008-11       Impact factor: 8.822

10.  FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States.

Authors:  Flora Tassone; Ka Pou Iong; Tzu-Han Tong; Joyce Lo; Louise W Gane; Elizabeth Berry-Kravis; Danh Nguyen; Lisa Y Mu; Jennifer Laffin; Don B Bailey; Randi J Hagerman
Journal:  Genome Med       Date:  2012-12-21       Impact factor: 11.117

View more
  37 in total

Review 1.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

2.  FMR1 genotype interacts with parenting stress to shape health and functional abilities in older age.

Authors:  Marsha Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith Dawalt; Mei Wang Baker; Paul J Rathouz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-13       Impact factor: 3.568

3.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

4.  FMR1 CGG Repeats: Reference Levels and Race-Ethnic Variation in Women With Normal Fertility (Study of Women's Health Across the Nation).

Authors:  Lisa M Pastore; Ani Manichaikul; Xin Q Wang; Joel S Finkelstein
Journal:  Reprod Sci       Date:  2016-02-22       Impact factor: 3.060

5.  Is Low FMR1 CGG Repeat Length in Males Correlated with Family History of BRCA-Associated Cancers? An Exploratory Analysis of Medical Records.

Authors:  Hallee C Adamsheck; Elizabeth M Petty; Jinkuk Hong; Mei W Baker; Murray H Brilliant; Marsha R Mailick
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

6.  Executive Functioning Mediates the Effect of Behavioral Problems on Depression in Mothers of Children With Developmental Disabilities.

Authors:  Wai Chan; Leann E Smith; Jan S Greenberg; Jinkuk Hong; Marsha R Mailick
Journal:  Am J Intellect Dev Disabil       Date:  2017-01

7.  Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.

Authors:  Marsha R Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith; Stephanie Sherman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-10-25       Impact factor: 3.568

8.  The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.

Authors:  Catharine Riley; Marsha Mailick; Elizabeth Berry-Kravis; Julie Bolen
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 9.  Newborn screening for fragile X syndrome.

Authors:  Flora Tassone
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

10.  CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size.

Authors:  Anna Lisa Ludwig; Glenda M Espinal; Dalyir I Pretto; Amanda L Jamal; Gloria Arque; Flora Tassone; Robert F Berman; Paul J Hagerman
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.